Elekta Kaiku pioneers the personalization of cancer care through advanced digital patient monitoring and support. It collaborates with life sciences partners to co-create therapy-specific modules that provide the most personalized patient support, optimizing the treatment journey while generating robust real-world data for post-marketing commitments.

Elekta Kaiku aims to enhance cancer care by personalizing treatment with intelligent digital solutions. Their platform integrates machine learning technologies to predict symptom onset and continuity, improving patient safety, satisfaction, and treatment coordination while providing structured real-world outcomes data for research and life sciences.

They maintain compliance with international standards and medical device legislation to ensure regulatory adherence for their partners' co-created modules.

The platform has shown significant impact, including a reduction in phone call burden for healthcare systems and earlier detection of symptoms, contributing to improved patient outcomes and efficient treatment management.